Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 908 Devices Inc.MASS · Entity 5564 | Director | June 11, 2025 | June 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
908 Devices Inc.
Report date June 11, 2025 · Filed June 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,957 |
Reported balance
After 2025-06-11 transaction · row 1
1 source rowRow 1 · 2025-06-11 · Exercise / conversion · Acquired 11,364 · Balance 25,957 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-06-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-11 · Exercise / conversion · Disposed 11,364 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
F2: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Singular Genomics Systems, Inc.
Report date February 21, 2025 · Filed February 25, 2025
Section 16 reporting ended · disclosed 2025-02-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.41 · Expires 2033-08-03 | Direct | 0 |
Reported balance
After 2025-02-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-21 · Disposition to issuer · Disposed 4,933 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the "Merger Agreement"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the "Option Payment"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration. F2: As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.16 · Expires 2034-05-29 | Direct | 0 |
Reported balance
After 2025-02-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-21 · Disposition to issuer · Disposed 1,850 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the "Merger Agreement"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the "Option Payment"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration. F2: As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the "Merger Agreement"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the "Option Payment"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration.
F2: As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2025 Filed Jun 13, 2025 20:19 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 11,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004806 · primarydocument.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,364 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2 · derivative.exercise_date: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:19 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 11,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-25-004806 · primarydocument.xml · nonDerivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 20:04 UTC | Singular Genomics Systems, Inc. OMIC · Entity 82741 | Disposition to issuerStock Option (Right to Buy) · Derivative | 1,850 | $8.84 Strike: $11.16 | $16,354.00 |
DisclosureSEC source: 0000950170-25-027092 · ownership.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,850 shares Expires 2034-05-29 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the "Merger Agreement"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the "Option Payment"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration. F1 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the "Merger Agreement"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the "Option Payment"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration. F2 · derivative.exercise_date: As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 20:04 UTC | Singular Genomics Systems, Inc. OMIC · Entity 82741 | Disposition to issuerStock Option (Right to Buy) · Derivative | 4,933 | $0.00 Strike: $22.41 | $0.00 |
DisclosureSEC source: 0000950170-25-027092 · ownership.xml · derivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,933 shares Expires 2033-08-03 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the "Merger Agreement"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the "Option Payment"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration. F1 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the "Merger Agreement"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the "Option Payment"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration. F2 · derivative.exercise_date: As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 15,996 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001562180-24-005060 · primarydocument.xml · derivative · entry 4 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,996 Underlying: Common Stock · 15,996 shares Expires 2033-06-15 F5 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 13, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 11,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005060 · primarydocument.xml · derivative · entry 3 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,364 Underlying: Common Stock · 11,364 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4 · derivative.exercise_date: The RSUs become fully vested on June 13, 2025 or the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F4 · derivative.expiration_date: The RSUs become fully vested on June 13, 2025 or the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 7,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005060 · primarydocument.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,777 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2 · derivative.exercise_date: The RSUs became fully vested on June 12, 2024, the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs became fully vested on June 12, 2024, the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 7,777 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-005060 · primarydocument.xml · nonDerivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 20:13 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004888 · primarydocument.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 682 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 20:13 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004888 · primarydocument.xml · nonDerivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2024 Filed May 31, 2024 18:32 UTC | Singular Genomics Systems, Inc. OMIC · Entity 82741 | GrantStock Option (Right to Buy) · Derivative | 55,500 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0000950170-24-067534 · ownership.xml · derivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,500 Underlying: Common Stock · 55,500 shares Expires 2034-05-29 F1 · derivative.exercise_date: The option shares vest and become exercisable upon the earlier of the 2025 Annual Meeting of Stockholders or May 29, 2025. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 16:23 UTC | Singular Genomics Systems, Inc. OMIC · Entity 82741 | GrantStock Option (Right to Buy) · Derivative | 148,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-23-044982 · doc4.xml · derivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,000 Underlying: Common Stock · 148,000 shares Expires 2033-08-03 F1 · derivative.exercise_date: Subject to the Reporting Person's continuing service, 1/3rd of such option grant will vest on the one year anniversary of the date of grant, with the remainder vesting in 24 equal monthly installments thereafter. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:52 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 12,076 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0001562180-23-005310 · primarydocument.xml · derivative · entry 4 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,076 Underlying: Common Stock, · 12,076 shares Expires 2033-06-15 F5 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 15, 2023, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:52 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Units · Derivative | 7,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005310 · primarydocument.xml · derivative · entry 3 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,777 Underlying: Common Stock · 7,777 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4 · derivative.exercise_date: The RSUs become fully vested on June 15, 2024 or the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F4 · derivative.expiration_date: The RSUs become fully vested on June 15, 2024 or the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:52 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 4,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005310 · primarydocument.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2 · derivative.exercise_date: The RSUs became fully vested on June 14, 2023, the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs became fully vested on June 14, 2023, the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:52 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 4,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-005310 · primarydocument.xml · nonDerivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| June 07, 2023 Filed Jun 14, 2023 20:14 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 681 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005151 · primarydocument.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682 Underlying: Common Stock · 1,363 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 07, 2023 Filed Jun 14, 2023 20:14 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 681 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-005151 · primarydocument.xml · nonDerivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:16 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 7,970 | $0.00 Strike: $14.15 | $0.00 |
DisclosureSEC source: 0001562180-22-005193 · primarydocument.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,970 Underlying: Common Stock, par value $0.001 · 7,970 shares Expires 2032-06-16 F3 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 16, 2022, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:16 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 4,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005193 · primarydocument.xml · derivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,771 Underlying: Common Stock, par value $0.001 · 4,771 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become fully vested on June 16, 2023 or the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become fully vested on June 16, 2023 or the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 20:13 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004912 · primarydocument.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,363 Underlying: Common Stock · 2,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 20:13 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 682 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004912 · primarydocument.xml · nonDerivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:22 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 2,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-078965 · tm2119282-2_4seq1.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,045 Underlying: Common Stock, par value $0.001 · 2,045 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:22 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 3,511 | $0.00 Strike: $42.79 | $0.00 |
DisclosureSEC source: 0001104659-21-078965 · tm2119282-2_4seq1.xml · derivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,511 Underlying: Common Stock, par value $0.001 · 3,511 shares Expires 2031-06-07 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.